| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 455.9 | 363.8 |
| Profit before tax | 27.4 | 4.6 |
| Net income | 22.4 | 1.1 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +1978.5% |
|---|---|
| Revenue, year on year | +25.3% |
| Operating margin | 7.3% |
10-Q filed with the SEC, NASDAQ: LFST. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
LifeStance Health Group, Inc.: key numbers
- Share price
- $14.17Close, Nov 17
- Market cap
- $5.39B
- Shares outstanding
- 380.19MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Services-Health ServicesSIC 8000
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from LifeStance Health Group, Inc.
All →LifeStance Health Group Insider TPG Gp a LLC Sells $485M of Stock
TPG Gp a LLC sold 37,233,110 shares of LifeStance Health Group, Inc. at $13.02 a share, worth $485M in total on Nov 12, 2026. Shares held after the trade: 42,458,592 (-46.7%).
- Value
- $485M
- Shares
- 37,233,110
- Price
- $13.02
- Holding change
- -46.7%
- Trade date
- Nov 12, 2026
LifeStance Health Group Insider Ryan Pardo Sells $40.9M of Stock
Ryan Pardo sold 2,804,505 shares of LifeStance Health Group, Inc. at $14.58 a share, worth $40.9M in total on Nov 10, 2026. Shares held after the trade: 334,935 (-86.9%).
- Value
- $40.9M
- Shares
- 2,804,505
- Average price
- $14.58
- Holding change
- -86.9%
- Trade date
- Nov 10, 2026
LifeStance Health Group Director Kenneth A. Burdick Sells $2.05M of Stock
Kenneth A. Burdick, Director, sold 141,589 shares of LifeStance Health Group, Inc. at $14.41 to $14.60 a share (average $14.51) in 2 transactions, worth $2.05M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 2,904,221 (-2.5%).
- Value
- $2.05M
- Shares
- 141,589
- Average price
- $14.51
- Role
- Director
- Holding change
- -2.5%
- Trade date
- Nov 9, 2026 to Nov 10, 2026
LifeStance Health Group COO Lisa K. Miller Sells $215K of Stock
Lisa K. Miller, COO, sold 14,663 shares of LifeStance Health Group, Inc. at $14.68 a share, worth $215K in total on Nov 11, 2026. Shares held after the trade: 251,904 (-5.5%).
- Value
- $215K
- Shares
- 14,663
- Price
- $14.68
- Role
- COO
- Holding change
- -5.5%
- Trade date
- Nov 11, 2026
LifeStance Health Group M&A Deal with Selling Stockholders
LifeStance Health Group, Inc. entered into an underwriting agreement for a secondary offering of 45,000,000 shares of common stock sold by existing stockholders. The company did not receive any proceeds from the sale, but it repurchased 2,000,000 of these shares from the underwriters as part of the transaction.
- Counterparty
- Selling Stockholders
LifeStance Health Group Financial Results
LifeStance Health Group reported Q3 2026 revenue of $455.9 million, a 25% increase year-over-year, driven by higher visit volumes and clinician growth. The company significantly improved profitability, reporting net income of $22.4 million compared to $1.1 million in the prior year, and raised its full-year 2026 revenue and Adjusted EBITDA guidance.
- Term
- Q3 2026
“The team delivered a tremendous quarter, with execution across the business driving results that once again exceeded our expectations. The strong momentum gives us the confidence to further raise our full-year 2026 outlook across all financial metrics, while our positive patient outcomes, most recently across TMS and Spravato, reflect our commitment to clinical excellence.”
Dave Bourdon, CEO of LifeStance